United States· US:72865-273_3f2f2d85-443a-46a1-a637-69b106156df4
Dabigatran Etexilate
A dabigatran etexilate product containing dabigatran etexilate mesylate, registered in United States by XLCare Pharmaceuticals, Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dabigatran etexilate is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AE07 (dabigatran etexilate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Dabigatran etexilate · ATC B01AE07
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dabigatran etexilate costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dabigatran etexilate · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.16
- IT Italy$2.17
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DABIGATRAN ETEXILATE MESYLATE
- Manufacturer
- XLCare Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- B01AE07
- ATC class
- Dabigatran etexilate
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11728652736060 CAPSULE in 1 BOTTLE (72865-273-60)
- ndc1172865-273-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for dabigatran etexilate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dabigatran etexilate · interactions on record
47 records
47 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under B01AE07
Dabigatran etexilate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b80085d8-97df-44bc-a167-c83aba69df69 GET /v1/drugs/b80085d8-97df-44bc-a167-c83aba69df69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "DABIGATRAN ETEXILATE MESYLATE",
"productndc": "72865-273",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA207961",
"marketing_category": "ANDA"
}See everything about dabigatran etexilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.